Milestone Pharmaceuticals Inc. (MIST) is a Biotechnology company in the Healthcare sector, currently trading at $2.03. It has a SharesGrow Score of 46/100, indicating a mixed investment profile with 2 out of 7 criteria passed.
Analyst consensus target is MIST = $8 (+294.1% upside).
Valuation: MIST trades at a trailing Price-to-Earnings (P/E) of -2.7 (S&P 500 average ~25).
Financials: revenue is $2M, -90%/yr average growth. Net income is $63M (loss), growing at -8.6%/yr. Net profit margin is -4078.8% (negative). Gross margin is 92.6% (+2.2 pp trend).
Balance sheet: total debt is $58M against $42M equity (Debt-to-Equity (D/E) ratio 1.4, moderate). Current ratio is 8.01 (strong liquidity). Debt-to-assets is 51.4%. Total assets: $114M.
Analyst outlook: 6 / 7 analysts rate MIST as buy (86%) — strong consensus.
SharesGrow 7-Criteria breakdown: Value 100/100 (Pass), Growth 15/100 (Fail), Past 0/100 (Fail), Health 50/100 (Partial), Moat 50/100 (Partial), Future 94/100 (Pass), Income 10/100 (Fail).
